Adoption of Dexmedetomidine in Different Doses at Different Timing in Perioperative Patients

Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requiremen...

Full description

Saved in:
Bibliographic Details
Published inBioMed research international Vol. 2022; no. 1; p. 4008941
Main Authors Xie, Jing, Feng, Shiqiang, Qu, Zhenhua
Format Journal Article
LanguageEnglish
Published United States Hindawi 2022
John Wiley & Sons, Inc
Subjects
Online AccessGet full text
ISSN2314-6133
2314-6141
2314-6141
DOI10.1155/2022/4008941

Cover

Abstract Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People’s Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.
AbstractList Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). 495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4  g/(kg·h) rate), groups A2, B2, and C2 (0.6  g/(kg·h) rate), and groups A3, B3, and C3 (0.8  g/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 ( ), but did not change significantly in groups A1, A2, and A3 ( ); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( ); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( ). the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8  g/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.
Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4  μ g/(kg·h) rate), groups A2, B2, and C2 (0.6  μ g/(kg·h) rate), and groups A3, B3, and C3 (0.8  μ g/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 ( P <0.05 ), but did not change significantly in groups A1, A2, and A3 ( P >0.05 ); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( P <0.05 ); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( P <0.05 ). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8  μ g/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.
Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People’s Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.
Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia.Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia.it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training).OBJECTIVEit was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training).495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups.METHODS495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups.the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05).RESULTSthe similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05).the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.CONCLUSIONthe optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.
Audience Academic
Author Qu, Zhenhua
Xie, Jing
Feng, Shiqiang
AuthorAffiliation Department of Anesthesiology, Xingtai People's Hospital, Xingtai, Hebei, China
AuthorAffiliation_xml – name: Department of Anesthesiology, Xingtai People's Hospital, Xingtai, Hebei, China
Author_xml – sequence: 1
  givenname: Jing
  surname: Xie
  fullname: Xie, Jing
  organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn
– sequence: 2
  givenname: Shiqiang
  surname: Feng
  fullname: Feng, Shiqiang
  organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn
– sequence: 3
  givenname: Zhenhua
  orcidid: 0000-0003-4809-538X
  surname: Qu
  fullname: Qu, Zhenhua
  organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35872874$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9rFDEQx4NU7A_75rMs-CLUs_m1yealcPS0FQr2ob4JIZudXFN2kzPZq_rfm-Wu11rQvEzIfPL9zjBziPZCDIDQG4I_ElLXpxRTesoxbhQnL9ABZYTPBOFkb3dnbB8d53yHy2mIwEq8QvusbiRtJD9A3-ddXI0-hiq6agG_BuhgjIPvfIDKh2rhnYMEYawWMUOuzPjk6cYPPiwn7BqSjytIZvT3UF2XUPL5NXrpTJ_heBuP0LfPn27OL2dXXy--nM-vZpZLMc4YAdNZwC21om05JswwIxSpMWmIBc4Uda2ixkpBlZPMlaataa1tDXS0tewInW10V-u2NGCLdzK9XiU_mPRbR-P135ngb_Uy3mvFsGS8KQLvtwIp_lhDHvXgs4W-NwHiOmsqFOcUC6EK-u4ZehfXKZT2JorVQqlaPlJL04P2wcXiaydRPZekDIVIVhfq7dO6dwU_jKcAHzaATTHnBG6HEKynBdDTAujtAhScPsOtH8003eLu-399Otl8uvWhMz_9_y3-AIX8vsI
CitedBy_id crossref_primary_10_1155_2024_9862705
Cites_doi 10.1111/pan.14248
10.1007/s11517-020-02159-z
10.3390/ani11113254
10.4103/aca.ACA_168_18
10.1016/j.compbiomed.2018.11.018
10.1253/circj.CJ-21-0131
10.4103/sja.SJA_653_17
10.1016/j.jbi.2019.103252
10.3934/mbe.2021418
10.1097/MD.0000000000014144
10.1001/jama.2019.0234
10.32604/cmes.2021.016728
10.12659/MSM.930197
10.5812/aapm.111272
10.1007/s12652-020-02883-2
10.4103/ija.IJA_168_21
10.4103/aer.AER_153_17
10.3892/etm.2020.8787
10.1001/jamasurg.2017.1505
10.1016/j.future.2020.03.039
10.1016/j.bjan.2020.08.005
10.1016/j.bbi.2020.10.008
10.1016/j.jcrc.2016.10.026
10.3390/molecules26123671
10.25122/jml-2019-0070
10.1007/s00432-019-03102-y
10.12659/MSM.929949
10.1016/j.ijcce.2020.12.004
10.3892/etm.2017.4335
10.4314/ahs.v18i4.48
ContentType Journal Article
Copyright Copyright © 2022 Jing Xie et al.
COPYRIGHT 2022 John Wiley & Sons, Inc.
Copyright © 2022 Jing Xie et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Jing Xie et al. 2022
Copyright_xml – notice: Copyright © 2022 Jing Xie et al.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: Copyright © 2022 Jing Xie et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2022 Jing Xie et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QO
7T7
7TK
7U7
7U9
7X7
7XB
88E
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
CWDGH
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
5PM
DOI 10.1155/2022/4008941
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Middle East & Africa Database
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Middle East & Africa Database
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Toxicology Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Publicly Available Content Database
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2314-6141
Editor Akhlaq, Muhammad
Editor_xml – sequence: 1
  givenname: Muhammad
  surname: Akhlaq
  fullname: Akhlaq, Muhammad
ExternalDocumentID PMC9307348
A711331735
35872874
10_1155_2022_4008941
Genre Retracted Publication
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID 04C
3V.
4.4
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
AAFWJ
AAJEY
AAWTL
ABDBF
ABUWG
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFKRA
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARAPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BMSDO
BPHCQ
BVXVI
CCPQU
CWDGH
DIK
EAD
EAP
EAS
EBD
EBS
ECF
ECT
EIHBH
EMB
EMK
EMOBN
ESX
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAG
IAO
IEA
IHR
INH
INR
IOF
ISR
ITC
KQ8
LK8
M1P
M48
M7P
ML0
ML~
OK1
P62
PIMPY
PQQKQ
PROAC
PSQYO
RHU
RHW
RHX
RPM
SV3
TUS
UKHRP
0R~
24P
AAYXX
ACCMX
ACUHS
ADOJX
ALIPV
CITATION
EJD
H13
PGMZT
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QL
7QO
7T7
7TK
7U7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c476t-31eadce0b2c6bb4013a3a69150181ce4392fb92ac7629f73f022cabccbaed2bc3
IEDL.DBID M48
ISSN 2314-6133
2314-6141
IngestDate Thu Aug 21 14:30:55 EDT 2025
Thu Sep 04 19:07:29 EDT 2025
Fri Jul 25 12:04:04 EDT 2025
Tue Jun 17 22:02:41 EDT 2025
Mon Jul 21 06:00:42 EDT 2025
Thu Apr 24 22:59:41 EDT 2025
Tue Jul 01 01:56:06 EDT 2025
Sun Jun 02 18:52:04 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2022 Jing Xie et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-31eadce0b2c6bb4013a3a69150181ce4392fb92ac7629f73f022cabccbaed2bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correction/Retraction-3
Academic Editor: Muhammad Akhlaq
ORCID 0000-0003-4809-538X
OpenAccessLink https://dx.doi.org/10.1155/2022/4008941
PMID 35872874
PQID 2693569957
PQPubID 237798
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307348
proquest_miscellaneous_2694420669
proquest_journals_2693569957
gale_infotracmisc_A711331735
pubmed_primary_35872874
crossref_primary_10_1155_2022_4008941
crossref_citationtrail_10_1155_2022_4008941
hindawi_primary_10_1155_2022_4008941
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle BioMed research international
PublicationTitleAlternate Biomed Res Int
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
References e_1_2_8_27_2
e_1_2_8_28_2
e_1_2_8_29_2
e_1_2_8_23_2
e_1_2_8_24_2
e_1_2_8_25_2
e_1_2_8_26_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_1_2
e_1_2_8_4_2
e_1_2_8_3_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_21_2
e_1_2_8_22_2
e_1_2_8_16_2
Shetty R. M. (e_1_2_8_18_2) 2018; 2
e_1_2_8_17_2
e_1_2_8_19_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
e_1_2_8_31_2
e_1_2_8_30_2
e_1_2_8_10_2
e_1_2_8_11_2
38230094 - Biomed Res Int. 2024 Jan 9;2024:9862705. doi: 10.1155/2024/9862705
References_xml – ident: e_1_2_8_27_2
  doi: 10.1111/pan.14248
– ident: e_1_2_8_14_2
  doi: 10.1007/s11517-020-02159-z
– volume: 2
  year: 2018
  ident: e_1_2_8_18_2
  article-title: BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization
  publication-title: The Cochrane Database Of Systematic Reviews
– ident: e_1_2_8_31_2
  doi: 10.3390/ani11113254
– ident: e_1_2_8_24_2
  doi: 10.4103/aca.ACA_168_18
– ident: e_1_2_8_20_2
  doi: 10.1016/j.compbiomed.2018.11.018
– ident: e_1_2_8_16_2
  doi: 10.1253/circj.CJ-21-0131
– ident: e_1_2_8_7_2
  doi: 10.4103/sja.SJA_653_17
– ident: e_1_2_8_13_2
  doi: 10.1016/j.jbi.2019.103252
– ident: e_1_2_8_21_2
  doi: 10.3934/mbe.2021418
– ident: e_1_2_8_22_2
  doi: 10.1097/MD.0000000000014144
– ident: e_1_2_8_4_2
  doi: 10.1001/jama.2019.0234
– ident: e_1_2_8_10_2
  doi: 10.32604/cmes.2021.016728
– ident: e_1_2_8_8_2
  doi: 10.12659/MSM.930197
– ident: e_1_2_8_1_2
  doi: 10.5812/aapm.111272
– ident: e_1_2_8_19_2
  doi: 10.1007/s12652-020-02883-2
– ident: e_1_2_8_26_2
  doi: 10.4103/ija.IJA_168_21
– ident: e_1_2_8_25_2
  doi: 10.4103/aer.AER_153_17
– ident: e_1_2_8_5_2
  doi: 10.3892/etm.2020.8787
– ident: e_1_2_8_9_2
  doi: 10.1001/jamasurg.2017.1505
– ident: e_1_2_8_12_2
  doi: 10.1016/j.future.2020.03.039
– ident: e_1_2_8_29_2
  doi: 10.1016/j.bjan.2020.08.005
– ident: e_1_2_8_2_2
  doi: 10.1016/j.bbi.2020.10.008
– ident: e_1_2_8_3_2
  doi: 10.1016/j.jcrc.2016.10.026
– ident: e_1_2_8_17_2
  doi: 10.3390/molecules26123671
– ident: e_1_2_8_6_2
  doi: 10.25122/jml-2019-0070
– ident: e_1_2_8_15_2
  doi: 10.1007/s00432-019-03102-y
– ident: e_1_2_8_23_2
  doi: 10.12659/MSM.929949
– ident: e_1_2_8_11_2
  doi: 10.1016/j.ijcce.2020.12.004
– ident: e_1_2_8_30_2
  doi: 10.3892/etm.2017.4335
– ident: e_1_2_8_28_2
  doi: 10.4314/ahs.v18i4.48
– reference: 38230094 - Biomed Res Int. 2024 Jan 9;2024:9862705. doi: 10.1155/2024/9862705
SSID ssj0000816096
Score 2.3186164
SecondaryResourceType retracted_publication
Snippet Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic...
Dexmedetomidine (Dex) is an alpha‐2 agonist used for sedation during various procedures. Dex activates 2‐adrenoceptors, and causes the decrease of sympathetic...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4008941
SubjectTerms Algorithms
Analgesia
Anesthesia
Artificial intelligence
Bayes Theorem
Bayesian analysis
Blood pressure
Cardiovascular disease
Classification
Decision trees
Dexmedetomidine
Dexmedetomidine - pharmacology
Dosage
Dosage and administration
Dose-response relationship (Biochemistry)
Drug dosages
Gynecology
Heart Rate
Hemodynamic responses
Humans
Hypnotics and Sedatives - pharmacology
Hypnotics and Sedatives - therapeutic use
Injection
K-nearest neighbors algorithm
Laparoscopy
Methods
Optimization
Pain perception
Patients
Perioperative care
Pharmacology, Experimental
Probability
Probability distribution
Receptors (physiology)
Side effects
Surgery
Sympathetic nervous system
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS9xAEB-qUPGltLXaWFu2YJ9K8C77lX08epWjYBFRuIdCyG42eqDJ0UTqn9-ZZC94arGPyc7uhvnYmdnd_AbgMDVSO13qWPkijUVe8Dj3iYmdxnAAk9xSdqA-Jz_V7EL8mMt5AElqHh_ho7ej9Dw5QlVLDf2gvpEqUt6z2XzYSqHaESPTl5EbC0yGOF9dcX_Qfc35hCX45RUlv38WT4WYD29K3nM9x6_hVYgZ2aQX8ht44au3sHUSTsV34NekqDvLZ3XJpv4OR_JtfbNAt-TZomLTUASlZdO68Q3L23uvzqms1yWRnaIy1kvfQ4Gz0x5wtXkHF8ffz7_N4lA1IXZCqxYXVVQO50c2ccpaSp9ynisz7pD7nMcAJCmtSXKURmJKzUvkj8utczb3RWId34XNqq78e2BozNpY7OB8IbQbWS_SER2slZbLUrkIvq7YmbkAKU6VLa6zLrWQMiPmZ4H5EXwZqJc9lMY_6A5IMhlZGI7mUN9dNtFjFOtYcxnBYZDYc6OsxJkFs2yyRBkulUH9jODz0EwT0FWzyte3HY0QBHJvItjrpT9MxGWqqUBABHpNLwYCAuteb6kWVx1ot6HFVKT7__f1H2CbHvu9ngPYbH_f-o8Y_bT2U6f7fwEysPrl
  priority: 102
  providerName: Hindawi Publishing
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwEB5BEagXxJtAQUYqJxR1E9txfEIrlqVCKuqhlXpAiuKJ064EyZakgp_PTOINXcTjGk_sxDMez4yt7wPYz602aGoTZ77KY1VWMi59amM0FA5QklvrAdTn6FN2eKo-numzUHDrwrXKjU8cHHXVItfID9LMSp1Z6vrt-jJm1ig-XQ0UGjfhVkI7Ddt5vvww1ViYVGJmR365RFGWJOXm7rvWnPanB2TCuVXJ1q4UfPPtC86Kv6_-FHv-foXy2p60vAd3QzAp5qP278MN3zyAO0fhuPwhfJ5X7eASRFuLhf9BPfm-_bqi_cqLVSMWgR2lF4u2850o-2uPTpjv65zFjslK27UfMcLF8YjE2j2C0-X7k3eHcaBTiFGZrCdvS1aDfuZSzJzjvKqUZWaTAdIPPUUmae1sWpKaUlsbWdP8YOkQXemr1KF8DDtN2_inIGiVG-voBfSVMjhzXuUzPnGrndR1hhG82UxngQFrnCkvvhRDzqF1wZNfhMmP4PUkvR4xNv4it8eaKXjpUW9ICwGLuUlIrYmROoL9oLH_9bJRZxHWa1f8sq4IXk3NPADfQWt8ezXIKMXo9zaCJ6P2p4Gkzg0zB0RgtuxiEmAU7-2WZnUxoHlb9rIqf_bvz3oOu_wTY_FnD3b6b1f-BYVDvXs52PxPfA0FXA
  priority: 102
  providerName: ProQuest
Title Adoption of Dexmedetomidine in Different Doses at Different Timing in Perioperative Patients
URI https://dx.doi.org/10.1155/2022/4008941
https://www.ncbi.nlm.nih.gov/pubmed/35872874
https://www.proquest.com/docview/2693569957
https://www.proquest.com/docview/2694420669
https://pubmed.ncbi.nlm.nih.gov/PMC9307348
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9swEBZdy8Zexn523rqgQfc0vMWWJVkPY2RLszBICaGBwBjGkuUl0Nlt47Luv9-dLIemdGwvBttnCe6-O93Z8neEHKaKSyNLGQpbpGGSFyzMbaxCIyEdgCK35I7UZ3IsxvPk64IvdkjXbdQrcH1raYf9pOYXp--uzn9_BIf_4Byec6zf4_eAxVThH-x7sCYJLMMmPtF3MTmNRF-1neaiBOolxrpd8DcG2FqffJS-u8T6-Nfqtiz05mbKa6vT6CF54NNKOmhx8Ijs2OoxuTfxH86fkOW3mW0cM3PxnQ6K2gUKWpd0aK9gVNvUP1ewilm6qujQ90xp6LBe2zXNm2uXTrAL2A8UmwJ2QVctczidtvys66dkPjo6-TwOfZOF0CRSNBCDAUvG9nVshNZYbeUsFypyRH_GQr4Sl1rFORgvVqVkJejK5NoYndsi1oY9I7tVXdnnhILvS6XhAWOLRJq-tknax-9wpWa8FCYgbzvVZsYzkGMjjNPMVSKcZ2iIzBsiIG820mct88Zf5A7QShlCBBUJ7mGygYzAxJFkPCCH3nr_GqUzbdaBMIuFYlwogHNAXm9u4wS4M62y9aWTSRLkxFcB2W-RsJmI8VRiP4GAyC2MbASQ23v7TrVaOo5vhbE3SV_8pxJekvt42r4bOiC7zcWlfQXZUqN75I5cSDimoy89svfp6Hg66znngONsvPgDg1UR5w
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIh4XxJtAASO1JxR149hxfEBoxVJtabfqYSvtASnEjkNXgmQhqQp_it_ITF50EY9Tr8nsJDtPz9iZD2A71lJZlSs_clnsizQL_dRx7VuFywEscnPZDPWZHUXTE_FuIRcb8KP_FoaOVfYxsQnUWWmpR77LIx3KSCPr16svPqFG0e5qD6HRmsWB-36OJVv1an-C-t3hfO_t_M3U71AFfCtUVGPQQeFZNzLcRsZQeZGGaaSDZrKddZigeW40T_Ftuc5VmGOWs6mx1qQu48aGyPcKXBXUGUf_UQs19HQIxGKkWzy7QGBVFob9WXspqc3Ad9FlYi2CtSzY5YJrp1SFny__tNb9_cjmhRy4dxtudYtXNm6t7Q5suOIuXJ912_P34P04K5sQxMqcTdw35OTq8vMS86Njy4JNOjSWmk3KylUsrS9cmhO-2EciO0avKFeunUnOjtvJr9V9OLkUQT-AzaIs3CNgGFWUNvgD6zKh7Mg4EY9ohy83ocwj68HLXpyJ7WabE8TGp6SpcaRMSPhJJ3wPdgbqVTvT4y90W6SZhFwduVl0PJuMVYBqDVQoPdjuNPY_Lr06ky4-VMkva_bgxXCbHkBn3gpXnjU0QtC0fe3Bw1b7w4NCGStCKvBArdnFQEBTw9fvFMvTZnq4pqgu4sf_fq3ncGM6nx0mh_tHB0_gJv2htvG0BZv11zP3FJditXnW2D-DD5ftcD8BFPFD5w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db5RAcFJrbHwxfla06pq0T4bcsQss-2DMRby01jb30Cb3YILssthLFE6hqf41f50zsJw948dTX9lhgPme3WEGYDdRkTSylH5si8QP80L4ueXKNxLDAUxyy6hr6nN0HO-fhm_n0XwDfgz_wlBZ5WATO0Nd1Ib2yEc8ViKKFaIela4sYpZOXy2_-DRBik5ah3EavYgc2u8XmL41Lw9S5PUe59M3J6_3fTdhwDehjFs0QEhIY8eam1hrSjVykccq6LrcGYvOmpda8RzfnKtSihI9nsm1MTq3BddGIN5rcF0KjKpQl-RcrvZ3aKDFWPWz7YIQMzQhhrr7KKItBz5C9UlUGKx5ROcXbpxRRn6x-FPc-3v55iV_OL0Nt1wgyya95N2BDVvdha0jd1R_D95PirozR6wuWWq_ISbb1p8X6CstW1QsdZNZWpbWjW1Y3l66dEKzxj4S2Aw1pF7avj85m_VdYJv7cHolhH4Am1Vd2YfA0MJIpfEGY4tQmrG2YTKm075Si6iMjQcvBnJmxvU5p3Ebn7Iu34mijIifOeJ7sLeCXvb9Pf4Ct0OcyUjtEZtBJTTZRAbI1gDZ78Gu49j_sAzszJytaLJfku3B89UyPYDq3ypbn3cwYUid95UH2z33Vw8SUSJpaoEHck0uVgDUQXx9pVqcdZ3EFVn4MHn079d6Bluoatm7g-PDx3CTvqffg9qBzfbruX2CUVmrn3biz-DDVevbT1h7SCY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%5BRetracted%5D+Adoption+of+Dexmedetomidine+in+Different+Doses+at+Different+Timing+in+Perioperative+Patients&rft.jtitle=BioMed+research+international&rft.au=Xie%2C+Jing&rft.au=Feng%2C+Shiqiang&rft.au=Qu%2C+Zhenhua&rft.date=2022&rft.issn=2314-6133&rft.eissn=2314-6141&rft.volume=2022&rft.issue=1&rft_id=info:doi/10.1155%2F2022%2F4008941&rft.externalDBID=n%2Fa&rft.externalDocID=10_1155_2022_4008941
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2314-6133&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2314-6133&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2314-6133&client=summon